Loading session...

AI Roundtable Debate · 4 models

It's better to build your own canonical list of US health insurance plans and entities than buy one.

Result: Unanimous — No (4/4 votes)

Options

Model Responses

Sonar Pro

Vote: No

Building a canonical list of US health insurance plans and entities from scratch is inefficient and risky compared to buying a pre-built one, given the availability of authoritative, regularly updated government datasets. CMS provides comprehensive, free Health Plan Finder Data (HIOS and RBIS) quarterly through 2026, covering individual and small group plans on HealthCare.gov[1]. Additional sources like Census Bureau tables[5], DOL Group Health Plan Data[6], and Healthcare.gov plan datasets[7] offer downloadable, structured data on plans, enrollment, and coverage, reducing the need for custom builds. Commercial options like AIS Health Data handle complexities such as name changes, mergers, state/national breakdowns, and duplicates, with features like MCO ID tracking and support for missing data[2]. These are more complete and current than manual aggregation, avoiding errors from outdated or incomplete public releases. Time, expertise, and maintenance costs for a custom list—tracking dynamic changes like acquisitions or new plans—are prohibitive. Buying leverages expert curation and updates, ensuring accuracy for critical applications.

GPT-5.4

Vote: No

Buying is usually better. A canonical US health insurance plan/entity list is not a static spreadsheet; it is a continuously changing reference dataset with mergers, rebrands, aliases, regional products, TPAs, delegated networks, and payer IDs that must be maintained over time. The hard part is not the initial build. The hard part is ongoing coverage, normalization, QA, and governance. Vendors spread that maintenance cost across many customers and often provide update processes, identifiers, hierarchy handling, and support that are expensive to recreate internally. Building your own only makes sense if your needs are unusually specialized, you already have strong internal data operations, and commercial sources fail on key requirements. For most organizations, buying a solid dataset and extending it internally is lower risk, faster to deploy, and cheaper in total cost of ownership.

Claude Opus 4.6

Vote: No

Building your own canonical list of US health insurance plans and entities is an enormously complex undertaking that is almost certainly not worth the effort compared to purchasing or licensing an existing dataset. The US health insurance landscape is incredibly fragmented and dynamic. There are thousands of plans across Medicare, Medicaid, individual marketplace, employer-sponsored, and other categories. Plans change every year — new ones are created, old ones are discontinued, and details like network compositions, plan IDs, and issuer information are constantly updated. Maintaining accuracy requires ongoing, dedicated effort. Established data vendors (like CMS's own public datasets, Vericred/Ideon, HealthSherpa, or other health data aggregators) have already invested millions of dollars and years of work into collecting, normalizing, and maintaining these lists. They have established relationships with carriers, automated data pipelines, and quality assurance processes. Replicating this infrastructure from scratch would be prohibitively expensive for most organizations. The opportunity cost is significant. Engineering and data teams that could be building core product features or business logic would instead be spending time on data collection, normalization, and maintenance — a commodity function that others have already solved. There are edge cases where building your own might make sense (e.g., you only need a very narrow slice of the market, or you have unique data quality requirements), but as a general statement, buying is almost always the better choice. The 'build vs. buy' calculus strongly favors buying when the domain is well-served by existing vendors and the data is complex and fast-changing.

Gemini 3.1 Pro

Vote: No

The US health insurance landscape is notoriously fragmented and volatile. With thousands of commercial payers, Medicare Advantage plans, Medicaid MCOs, and Third-Party Administrators (TPAs), the market is in a constant state of flux due to frequent mergers, acquisitions, and yearly regulatory changes. Building a canonical list from scratch is not a one-time project; it is an endless maintenance burden. Attempting to track these changes across 50 state insurance departments, CMS, and private entities requires dedicated data stewardship and engineering resources. This diverts your team's focus and budget away from your actual core product. Buying this data from an established vendor or clearinghouse leverages economies of scale. Specialized healthcare data aggregators dedicate their entire business to maintaining accurate, up-to-date payer registries. Buying access guarantees higher accuracy, standardized formatting, and continuous updates at a fraction of the long-term operational cost of building and maintaining it in-house.

Final Summary

The AI Roundtable reached an immediate and unanimous consensus, effectively staging an intervention against anyone considering a DIY approach to health insurance data. Claude Opus 4.6, Gemini 3.1 Pro, GPT-5.4, and Sonar Pro all concluded that the 'build' path is a trap, citing the staggering complexity of tracking thousands of plans across 50 state jurisdictions. The models collectively warned that the initial data collection is a minor hurdle compared to the permanent, soul-crushing burden of maintaining a list in a market defined by constant mergers and regulatory shifts.

All 4 models agreed on "No" after discussion

Strongest Arguments

  • No: The true cost of a canonical list isn't the initial build, but the ongoing governance, normalization, and hierarchy management required to track a 'moving target' landscape where vendors spread maintenance costs across hundreds of customers.